行情

NYMX

NYMX

耐莫斯制药
NASDAQ

实时行情|Nasdaq Last Sale

3.100
-0.120
-3.73%
盘后: 3.100 0 0.00% 16:00 07/13 EDT
开盘
3.220
昨收
3.220
最高
3.270
最低
3.090
成交量
14.26万
成交额
--
52周最高
4.790
52周最低
1.580
市值
2.22亿
市盈率(TTM)
-16.7296
分时
5日
1月
3月
1年
5年

NYMX 新闻

更多
Nymox (+8%) on track to file fexapotide applications in ~four months
Seeking Alpha - Article · 06/19 15:54
Nymox Announces Updates in Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
GlobeNewswire · 06/19 14:30
Nymox Pharma Offers Update On Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is very pleased to report that key steps in its regulatory submission preparations have been completed and the project is firmly on-track. The majority of its regulatory
Benzinga · 06/19 13:31
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16)
Benzinga · 06/16 12:15
Hedge Funds Cautiously Watching Pharmaceutical Corporation (NYMX)
Insider Monkey · 06/05 20:16
If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You'd Have Made 91%
Simply Wall St. · 05/05 14:08
Nymox Announces Important New Patent Developments
GlobeNewswire · 04/21 13:45
Nymox Pharmaceutical Corp Files For Mixed Shelf Offering Of Up To $12M
-Reuters
Reuters · 04/03 17:54

所属板块

生物技术和医学研究
-1.74%
制药与医学研究
-0.02%

热门股票

代码
价格
涨跌幅

NYMX 简况

Nymox Pharmaceutical Corp是一家加拿大的生物制药公司。该公司主要开发候选药物NX-1207,用于治疗良性前列腺增生(BPH)和低级局部前列腺癌。该公司运营人口老化产品研发部门。该公司进行NicAlert和TobacAlert市场测试,该测试用尿液或唾液检测烟草制品的使用情况。该公司还持有上市产品、研究药物以及其他治疗和诊断适应症的拥有权。该公司还有权使用他汀类药物防治阿尔茨海默病。该公司的子公司包括Nymox Corporation和Serex, Inc.。Nymox Corporation从事研发业务,而Serex, Inc.从事NicAlert和TobacAlert的研发和生产业务。
展开

微牛提供Nymox Pharmaceutical Corp(NASDAQ-NYMX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的NYMX股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NYMX股票基本功能。